AcuraStem, a biotechnology company advancing treatments for amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD), and other neurodegenerative diseases, announced today that the ...
Researchers at University of California San Diego School of Medicine, the Salk Institute and Sanford Burnham Prebys have ...
Last week, the California Institute for Regenerative Medicine (CIRM) approved a new funding program aimed at accelerating gene therapies for rare diseases by moving away from traditional approaches ...
UC San Diego, the Salk Institute, and Sanford Burnham Prebys have secured a $13 million CIRM grant to study how 'RNA pollution' in aging neurons contributes to neurodegenerative diseases like ...
South San Francisco, Calif., Jan. 30, 2026 (GLOBE NEWSWIRE) -- The California Institute for Regenerative Medicine (CIRM) has approved a new funding program to accelerate therapies for rare diseases, ...
WOODBRIDGE, Conn.--(BUSINESS WIRE)--Cure Rare Disease (CRD) announced it has been awarded a $5.69 million grant from the California Institute for Regenerative Medicine (CIRM) to advance the ...
Institute also doled out its third Research Leadership award totaling $5.6 million. The California Institute for Regenerative Medicine (CIRM) reports that it has approved $27 million for two funds, ...
Re “Stem cell funding debate” (Sept. 26): Based solely on the arguments posed in the op-ed section, the winner, hands down in my opinion, is John Moorlach, who reasoned that very little in the way of ...
Klein said that through discussions in June and July, the board confirmed a policy that precluded candidates who wish to maintain active labs during their term as CIRM president. Previously, such ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results